Cardiosave Hybrid IABP - Product Usage: used to inflate and deflate intra-aortic balloons. It pro...
FDA Device Recall #Z-1506-2021 — Class III — March 22, 2021
Recall Summary
| Recall Number | Z-1506-2021 |
| Classification | Class III — Low risk |
| Date Initiated | March 22, 2021 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Datascope Corp. |
| Location | Mahwah, NJ |
| Product Type | Devices |
| Quantity | 10087 total |
Product Description
Cardiosave Hybrid IABP - Product Usage: used to inflate and deflate intra-aortic balloons. It provides temporary support to the left ventricle via the principle of counterpulsation, Model Numbers 0998-00-0800-32, 0998-00-0800-33, 0998-00-0800-34, 0998-00-0800-35, 0998-00-0800-45, 0998-00-0800-52, 0998-00-0800-53, 0998-00-0800-55, 0998-00-0800-65
Reason for Recall
There are cybersecurity vulnerabilities in a widely used low-level TCP/IP software library that may result in a loss of communication to the Hospital Information System/Clinical Information System (HIS/CIS).
Distribution Pattern
Worldwide distribution - US Nationwide distribution.
Lot / Code Information
All Systems. UDI: 10607567111117 10607567109008 10607567111940 10607567109107 10607567108421 10607567108438 10607567108391 10607567108414 10607567113432
Other Recalls from Datascope Corp.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1587-2026 | Class III | Battery Charging Station; Model: 0998-00-0802; | Feb 6, 2026 |
| Z-1487-2026 | Class II | CS300 IABP. Software Version CS300 IABP C.01. | Jan 23, 2026 |
| Z-1486-2026 | Class II | CS100 IABP. Software Version CS100 IABP Q.01. | Jan 23, 2026 |
| Z-0916-2026 | Class II | Cardiosave Hybrid. Intra-Aortic Balloon Pump sy... | Nov 4, 2025 |
| Z-0917-2026 | Class II | Cardiosave Rescue. Intra-Aortic Balloon Pump sy... | Nov 4, 2025 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.